{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:51:09Z","timestamp":1761540669510,"version":"3.44.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1053\/j.seminhematol.2004.07.005","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"287-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gene therapy of the hemophilias"],"prefix":"10.1053","volume":"41","author":[{"given":"Jay","family":"Lozier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2004.07.005_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.1994.03510250063036","article-title":"Gene therapy and the hemophilias","volume":"271","author":"Lozier","year":"1994","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00043426-199123000-00006","article-title":"Prophylaxis with factor concentrates in preventing hemophilic arthropathy","volume":"13","author":"Petrini","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib4","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446","article-title":"Further characterization of factor VIII-deficient mice created by gene targeting","volume":"88","author":"Bi","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib5","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1182\/blood.V90.10.3962","article-title":"A coagulation factor IX-deficient mouse model for human hemophilia B","volume":"90","author":"Lin","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib6","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.94.21.11563","article-title":"A factor IX-deficient mouse model for hemophilia B gene therapy","volume":"94","author":"Wang","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.V92.1.168.413k06_168_174","article-title":"Targeted inactivation of the coagulation factor IX gene causes hemophilia B in mice","volume":"92","author":"Kundu","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1084\/jem.90.2.97","article-title":"Canine hemophilia","volume":"90","author":"Graham","year":"1949","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib9","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1073\/pnas.192219599","article-title":"The Chapel Hill hemophilia A dog colony exhibits an inversion of the factor VIII gene","volume":"99","author":"Lozier","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1055\/s-0037-1613063","article-title":"Aberrant splicing and premature termination of transcription of the FVIII gene as a cause of severe canine hemophilia A","volume":"87","author":"Hough","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V60.3.727.727","article-title":"A canine model of hemophilic (factor VIII:C deficiency) bleeding","volume":"60","author":"Giles","year":"1982","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1193-236","article-title":"Inversions disrupting the factor VIII gene are a common cause of severe hemophilia A","volume":"5","author":"Lakich","year":"1993","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/hmg\/2.11.1773","article-title":"Characteristic mRNA abnormality found in half the patients with severe hemophilia A is due to large DNA inversions","volume":"2","author":"Naylor","year":"1993","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib14","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood.V86.6.2206.bloodjournal8662206","article-title":"Factor VIII gene inversions in severe hemophilia A","volume":"86","author":"Antonarakis","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0888-7543(92)90170-W","article-title":"Sequence of the human factor VIII-associated gene is conserved in mouse","volume":"13","author":"Levinson","year":"1992","journal-title":"Genomics"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib16","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nm900","article-title":"Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Chao","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib17","doi-asserted-by":"crossref","first-page":"10095","DOI":"10.1073\/pnas.86.24.10095","article-title":"Canine hemophilia B resulting from a point mutation with unusual consequences","volume":"86","author":"Evans","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1055\/s-0037-1614021","article-title":"Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony","volume":"84","author":"Herzog","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1055\/s-0037-1613091","article-title":"Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys","volume":"87","author":"McCarthy","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/4743","article-title":"Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector","volume":"5","author":"Herzog","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/4751","article-title":"Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors","volume":"5","author":"Snyder","year":"1999","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/sj.gt.3301024","article-title":"Persistent expression of canine factor IX in hemophilia B canines","volume":"6","author":"Chao","year":"1999","journal-title":"Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib23","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1182\/blood-2003-01-0314","article-title":"A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia","volume":"102","author":"Ehrhardt","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.gt.3300548","article-title":"Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia","volume":"5","author":"Monahan","year":"1998","journal-title":"Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mthe.2000.0031","article-title":"Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver","volume":"1","author":"Wang","year":"2000","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib26","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V88.9.3451.bloodjournal8893451","article-title":"A deletion mutation causes hemophilia B in Lhasa Apso dogs","volume":"88","author":"Mauser","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib27","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood.V99.8.2670","article-title":"Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy","volume":"99","author":"Mount","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1089\/104303402760128559","article-title":"Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector","volume":"13","author":"Andrews","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib29","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1182\/blood.V94.12.3968","article-title":"Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity","volume":"94","author":"Lozier","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.gt.3300412","article-title":"Adenovirus-mediated gene transfer","volume":"4","author":"Michou","year":"1997","journal-title":"Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib31","first-page":"163a","article-title":"The mouse MHC locus is the major genetic factor that controls the antibody response to human factor IX in mice","volume":"102","author":"Lozier","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood.V93.6.1875.406k16_1875_1881","article-title":"The rhesus macaque as an animal model for hemophilia B gene therapy","volume":"93","author":"Lozier","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/10430340152712665","article-title":"Toxicity of a first-generation adenoviral vector in rhesus macaques","volume":"13","author":"Lozier","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib34","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2002-02-0589","article-title":"Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques","volume":"100","author":"Nathwani","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib35","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1182\/blood.V96.5.1698","article-title":"Immune tolerance induction in hemophilia patients with inhibitors","volume":"96","author":"Colowick","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2004.07.005_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1423-0410.1999.tb00019.x","article-title":"Factor IX antibody and immune tolerance","volume":"77","author":"Warrier","year":"1999","journal-title":"Vox Sang"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00043426-199701000-00003","article-title":"Factor IX inhibitors and anaphylaxis in hemophilia B","volume":"19","author":"Warrier","year":"1997","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib38","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1182\/blood.V89.3.1115","article-title":"Nephrotic syndrome as a complication of immune tolerance in hemophilia B","volume":"89","author":"Ewenstein","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib39","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood.V97.10.3311","article-title":"Induction of tolerance to human factor VIII in mice","volume":"97","author":"Chao","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/hum.1995.6.2-185","article-title":"In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice","volume":"6","author":"Connelly","year":"1995","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib41","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1182\/blood.V87.11.4671.bloodjournal87114671","article-title":"Sustained expression of therapeutic levels of human factor VIII in mice","volume":"87","author":"Connelly","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib42","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1182\/blood.V88.10.3846.bloodjournal88103846","article-title":"Complete short-term correction of canine hemophilia A by in vivo gene therapy","volume":"88","author":"Connelly","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib43","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V91.9.3273","article-title":"Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy","volume":"91","author":"Connelly","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/mthe.2001.0264","article-title":"Generation and characterization of E1\/E2a\/E3\/E4-deficient adenoviral vectors encoding human factor VIII","volume":"3","author":"Andrews","year":"2001","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1089\/10430340152528147","article-title":"Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion","volume":"12","author":"Bristol","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/blood.V97.1.107","article-title":"Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs","volume":"97","author":"Gallo-Penn","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib47","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2002-03-0823","article-title":"Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors","volume":"101","author":"Chuah","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib48","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V95.3.820.003k32_820_828","article-title":"Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector","volume":"95","author":"Balague","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib49","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1073\/pnas.96.22.12725","article-title":"Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein","volume":"96","author":"Burton","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib50","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/blood-2003-01-0222","article-title":"Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII","volume":"102","author":"Scallan","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib51","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1006\/mthe.2002.0607","article-title":"Expression of human factor VIII by splicing between dimerized AAV vectors","volume":"5","author":"Chao","year":"2002","journal-title":"Mol Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1538-7836.2003.00096.x","article-title":"A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype","volume":"1","author":"Sarkar","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib53","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2003-01-0292","article-title":"Sustained phenotypic correction of canine hemophilia A using an adeno-associated viral vector","volume":"102","author":"Scallan","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib54","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-08-2954","article-title":"Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype","volume":"103","author":"Sarkar","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib55","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1073\/pnas.96.18.10379","article-title":"Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice","volume":"96","author":"Vandendriessche","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib56","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V96.3.1173.015k34_1173_1176","article-title":"Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver","volume":"96","author":"Park","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ng1293-397","article-title":"Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice","volume":"5","author":"Smith","year":"1993","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib58","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1073\/pnas.91.6.2353","article-title":"In vivo hepatic gene therapy","volume":"91","author":"Kay","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib59","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1182\/blood.V99.11.3923","article-title":"A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo","volume":"99","author":"Ehrhardt","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib60","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.94.11.5804","article-title":"Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus","volume":"94","author":"Herzog","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/blood.V100.1.153","article-title":"Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo","volume":"100","author":"Gui","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib62","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1182\/blood.V95.8.2536","article-title":"Improved muscle-derived expression of human coagulation factor IX from a skeletal actin\/CMV hybrid enhancer\/promoter","volume":"95","author":"Hagstrom","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib63","first-page":"154a","article-title":"Immune responses to AAV and to factor IX in a phase I study of AAV-mediated, liver-directed gene transfer for hemophilia B","volume":"102","author":"High","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2003-05-1446","article-title":"Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1","volume":"103","author":"Arruda","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib65","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","article-title":"Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy","volume":"102","author":"Grimm","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib66","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1128\/JVI.76.20.10497-10502.2002","article-title":"Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector","volume":"76","author":"Mingozzi","year":"2002","journal-title":"J Virol"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib67","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJM200106073442301","article-title":"Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A","volume":"344","author":"Roth","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib68","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2003-01-0167","article-title":"Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion","volume":"102","author":"Powell","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-0037-1615880","article-title":"Animal testing of retroviral-mediated gene therapy for factor VIII deficiency","volume":"82","author":"Greengard","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib70","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","article-title":"AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B","volume":"101","author":"Manno","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/73464","article-title":"Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector","volume":"24","author":"Kay","year":"2000","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib72","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1089\/10430340050015716","article-title":"The use of adeno-associated virus to circumvent the maturation-dependent viral transduction of muscle fibers","volume":"11","author":"Pruchnic","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1053\/j.seminhematol.2004.07.005_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:15:47Z","timestamp":1758521747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196304001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0037196304001283"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.07.005","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy of the hemophilias","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}